Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

Mol Psychiatry. 2011 Nov;16(11):1068-70. doi: 10.1038/mp.2011.47. Epub 2011 Apr 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amino Acid Substitution
  • Animals
  • Antidepressive Agents / pharmacology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / enzymology*
  • Depression / drug therapy
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Electroshock
  • Gene Knock-In Techniques
  • Glycogen Synthase Kinase 3 / antagonists & inhibitors*
  • Glycogen Synthase Kinase 3 / chemistry
  • Glycogen Synthase Kinase 3 / genetics
  • Glycogen Synthase Kinase 3 / physiology
  • Glycogen Synthase Kinase 3 beta
  • Helplessness, Learned
  • Hippocampus / drug effects
  • Hippocampus / enzymology*
  • Ketamine / pharmacology*
  • Lithium Chloride / pharmacology
  • Mice
  • Nerve Tissue Proteins / antagonists & inhibitors*
  • Nerve Tissue Proteins / chemistry
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / physiology
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism*
  • Point Mutation
  • Protein Processing, Post-Translational / drug effects

Substances

  • Antidepressive Agents
  • Nerve Tissue Proteins
  • Phosphoserine
  • Ketamine
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
  • glycogen synthase kinase 3 alpha
  • Lithium Chloride